Journal of Drug Issues 2011;41(4):441-46.
Aimee N.C. Campbell, MSW, PhD (New York State Psychiatric Institute, GNY Node), Bryan Hartzler, PhD (Alcohol & Drug Abuse Institute, PN Node), Mary A. Hatch-Maillette, PhD (Alcohol & Drug Abuse Institute, PN Node), Donald A. Calsyn, PhD (Alcohol & Drug Abuse Institute, PN Node), Gloria M. Miele, PhD (New York State Psychiatric Institute, GNY Node), Susan Tross, PhD (New York State Psychiatric Institute, GNY Node).
Research-based approaches to HIV risk reduction are available but not readily adopted by community-based treatment programs. This exploratory survey study assessed staff (N=116) attitudes as a function of direct research participation, treatment program type, and study performance within 7 methadone maintenance and 8 psychosocial outpatient substance abuse treatment programs that participated in the National Drug Abuse Treatment Clinical Trials Network HIV risk-reduction trials (CTN-0018 and CTN-0019). Clinical staff who directly participated in the research reported intervention components as useful and were more likely to report perceived increases in HIV testing/referrals compared to staff who did not directly participate. However, those directly involved reported less positive attitudes about clinical impact and research impression. Results suggest a positive influence of research participation on awareness of program services, but also the need to address practical and professional issues related to research collaboration.
Conclusions: Effectiveness trials, such as those conducted within the CTN, offer a valuable opportunity to assess provider-level factors associated with adoption and implementation. This study supports continued research on effective methodology for collaboration between investigators and providers to influence post-study implementation. (Article (Peer-Reviewed), PDF, English, 2011)
Keywords: Adoption of interventions | Attitudes of health personnel | Clinician Exit Survey | Community health services | Counselors | CTN platform/ancillary study | Effectiveness trials | HIV/AIDS | Research participation | Sexual risk behavior | Sexually transmitted diseases | Journal of Drug Issues (journal)
Document No: 689, PMCID: PMC3536537.
Submitted by Donald Calsyn, PhD, Pacific Northwest Node, 1/17/2012.